個(gè)人簡介:
首都醫(yī)科大學(xué)附屬北京世紀(jì)壇醫(yī)院內(nèi)科主任、心血管內(nèi)科副主任(主持工作),心導(dǎo)管室主任,主任醫(yī)師,教授,博士生導(dǎo)師。注重冠心病的臨床及介入治療,對高血壓、高血脂、心力衰竭及疑難危重癥的診斷和治療經(jīng)驗(yàn)豐富。
社會(huì)兼職
第九、十、十一屆北京市青年聯(lián)合會(huì)委員
第四屆中央國家機(jī)關(guān)青年聯(lián)合會(huì)委員
第四屆中國青年科技工作者協(xié)會(huì)生物與醫(yī)藥專業(yè)委員會(huì)委員
學(xué)術(shù)兼職
中華醫(yī)學(xué)會(huì)心血管病分會(huì)精準(zhǔn)醫(yī)學(xué)學(xué)組委員
北京醫(yī)學(xué)會(huì)心血管病學(xué)分會(huì)常務(wù)委員
北京醫(yī)學(xué)會(huì)內(nèi)科學(xué)分會(huì)委員
中國衛(wèi)生信息與健康醫(yī)療大數(shù)據(jù)學(xué)會(huì)心腦血管專業(yè)委員會(huì)委員
中國醫(yī)師協(xié)會(huì)基層工作委員會(huì)常務(wù)委員
中國醫(yī)學(xué)救援協(xié)會(huì)心血管急救分會(huì)委員
世界中醫(yī)藥學(xué)會(huì)聯(lián)合會(huì)介入心臟病專業(yè)委員會(huì)常務(wù)理事
美國SCAI學(xué)會(huì)國際會(huì)士
作為項(xiàng)目負(fù)責(zé)人承擔(dān)了北京市自然科學(xué)基金、北京市科技新星計(jì)劃、北京市優(yōu)秀人才項(xiàng)目等省部級(jí)課題共計(jì)8項(xiàng)。
1. mIR-133在多柔比星誘導(dǎo)性心臟病超急性期中的作用及相關(guān)分子機(jī)制研究,北京市自然科學(xué)基金,自然類,省部級(jí),2016-1至2018-6,項(xiàng)目負(fù)責(zé)人
2. 早期超濾治療急性心肌梗死合并頑固性心力衰竭研究,北京市屬醫(yī)院科研培育計(jì)劃,自然類,校局級(jí),2016-1至2018-12,項(xiàng)目負(fù)責(zé)人
發(fā)表論著60余篇,參編學(xué)術(shù)專著4部,副主編1部。
第一作者或通訊作者:
1. Association of Monocyte Count on Admission with the Angiographic Thrombus Burden in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Clin Appl Thromb Hemost. 2018 Jan 1: 1076029618761005.
2. Association of Monocyte Count on Admission with the Angiographic Thrombus Burden in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Arq Bras Cardiol. 2018 Mar 12; 110(4):333-338.
3. The relationship between post-procedural platelet count and left ventricular aneurysm in patients with acute anterior ST-segment elevation myocardial infarction following primary percutaneous coronary intervention. Kardiol Pol. 2018;76(5):899-907.
4. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Kardiol Pol. 2016;74(10):1160-1166.
5. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Acta Cardiol. 2016 Apr;71(2):241-6.
6. Altered Therapeutic Window of Coronary Heart Disease Treatment Drug Clopidogrel in Drug-Induced Cholestasis Patients. Lat. Am. J. Pharm. 2016;35(5A):1269-72.
7. Conservative pharmacotherapy vs. staged percutaneous coronary intervention for non-culprit vessels in patients with ST-segment elevation myocardial infarction. Exp Ther Med. 2016 Dec;12(6):4147-4153.
8. Risk factors for carotid artery stenosis in chinese patients undergoing coronary artery bypass graft interventions. Medcine 94(28) e1119.